TAK Takeda Pharmaceutical
- 13.420
- -0.030-0.22%
- 13.260
- -0.160-1.19%
Takeda Pharmaceutical News
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Semi-annual Securities Report
6-K: Earnings Report for the Six-month Period Ended September 30, 2024
6-K: Notice of the Revised Forecast of Consolidated Financials for FY2024
6-K: Earnings Report for the Three-month Period Ended June 30, 2024
6-K: Corporate Governance Report
6-K: 2024 Annual Integrated Report
20-F: FY2024 Annual Report
6-K: Notice of Resolutions at the 148th Ordinary General Meeting of Shareholders
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
Takeda Pharmaceutical | 6-K: Quarterly Securities Report For The Nine-month Period and Three-month Quarter Ended December 31, 2023
Takeda Pharmaceutical | 6-K: Summary of Financial Statements for the Nine-month Period Ended December 31, 2023
Takeda Pharmaceutical | 6-K: Partial Amendment to Corporate Governance Report
No Data
